Canopus Biopharma Inc (CBIA)

[PENNYS ToMILLIONS]

Date of Note Issuance Outstanding Balance ($) Principal
Amount at Issuance ($) Interest Accrued ($) Maturity Date
Conversion Terms (e.g. pricing mechanism for determining conversion of instrument to shares)Name of Noteholder (entities must have
individual with voting / investment control disclosed).
Reason for Issuance (e.g. Loan, Services, etc.)
2/14/22 10,519 10,000 519 Maturity date 2/14/24 Not convertible Altus Advisors – Bryan Kessinger
Operating Expenses

12/12/22 153,205 150,000 3,205 Maturity date 3/31/24 30% discount on 3 lowest prices of 15 days
lookback PIPE QOF, Inc – Andrew Van Noy
Consulting Services

1/30/23 20,159 20,000 159 Maturity date 1/23/24 Not convertible Altus Advisors – Bryan Kessinger
Operating Expense
https://www.otcmarkets.com/otcapi/company/financial-report/376901/content